Search

3 result(s) for 'author#Brad H Rovin' within BMC

1. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

   TNF-like weak inducer of apoptosis (TWEAK) has been implicated as a mediator of chronic inflammatory processes via prolonged activation of the NF-κB pathway in several tissues, including the kidney. Evidence f...

   Authors: Noa Schwartz, Tamar Rubinstein, Linda C Burkly, Christopher E Collins, Irene Blanco, Lihe Su, Bernard Hojaili, Meggan Mackay, Cynthia Aranow, William Stohl, Brad H Rovin, Jennifer S Michaelson and Chaim Putterman

   Citation: Arthritis Research & Therapy 2009 11:R143

   Content type: Research article Published on: 28 September 2009

   • View Full Text
   • View PDF

2. A mathematical model of venous neointimal hyperplasia formation

   In hemodialysis patients, the most common cause of vascular access failure is neointimal hyperplasia of vascular smooth muscle cells at the venous anastomosis of arteriovenous fistulas and grafts. The release ...

   Authors: Paula Budu-Grajdeanu, Richard C Schugart, Avner Friedman, Christopher Valentine, Anil K Agarwal and Brad H Rovin

   Citation: Theoretical Biology and Medical Modelling 2008 5:2

   Content type: Research Published on: 23 January 2008

   • View Full Text
   • View PDF

3. Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers

   Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, b...

   Authors: Paula Budu-Grajdeanu, Richard C Schugart, Avner Friedman, Daniel J Birmingham and Brad H Rovin

   Citation: Theoretical Biology and Medical Modelling 2010 7:14

   Content type: Research Published on: 17 May 2010

   • View Full Text
   • View PDF